An activated mutant BRAF kinase domain is sufficient to induce pilocytic astrocytoma in mice
Open Access
- 1 April 2011
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 121 (4), 1344-1348
- https://doi.org/10.1172/JCI44656
Abstract
Pilocytic astrocytoma (PA) is the most common type of primary brain tumor in children and the second most frequent cancer in childhood. Children with incompletely resected PA represent a clinically challenging patient cohort for whom conventional adjuvant therapies are only moderately effective. This has produced high clinical demand for testing of new molecularly targeted treatments. However, the development of new therapeutics for PA has been hampered by the lack of an adequate in vivo tumor model. Recent studies have identified activation of MAPK signaling, mainly by oncogenic BRAF activation, as a hallmark genetic event in the pathogenesis of human PA. Using in vivo retroviral somatic gene transfer into mouse neural progenitor cells, we have shown here that ectopic expression of the activated BRAF kinase domain is sufficient to induce PA in mice. Further in vitro analyses demonstrated that overexpression of activated BRAF led to increased proliferation of primary mouse astrocytes that could be inhibited by treatment with the kinase inhibitor sorafenib. Our in vivo model for PA shows that the activated BRAF kinase domain is sufficient to induce PA and highlights its role as a potential therapeutic target.Keywords
This publication has 17 references indexed in Scilit:
- Activated BRAF induces gliomas in mice when combined with Ink4a/Arf loss or Akt activationOncogene, 2009
- Duplication of 7q34 in Pediatric Low‐Grade Astrocytomas Detected by High‐Density Single‐Nucleotide Polymorphism‐Based Genotype Arrays Results in a Novel BRAF Fusion GeneBrain Pathology, 2009
- Modeling Adult Gliomas Using RCAS/t-va TechnologyTranslational Oncology, 2009
- Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytomaOncogene, 2009
- Constitutive Activation of Raf-1 Induces Glioma Formation in MiceNeoplasia, 2008
- BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomasJCI Insight, 2008
- V600E B-Raf requires the Hsp90 chaperone for stability and is degraded in response to Hsp90 inhibitorsProceedings of the National Academy of Sciences of the United States of America, 2005
- Cell Type-Specific Tumor Suppression by Ink4a and Arf in Kras-Induced Mouse GliomagenesisCancer Research, 2005
- Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt.2002
- Cerebellar pilocytic astrocytoma: a treatment protocol based upon analysis of 73 cases and a review of the literatureChild's Nervous System, 1997